Cargando…

Exploring the mechanism of Semen Strychni in treating amyotrophic lateral sclerosis based on network pharmacology

Semen Strychni (SS), known as an agonist of central nervous system, is a traditional herb widely used in treating amyotrophic lateral sclerosis (ALS) in small doses to relieve muscle weakness and improve muscle strength. However, the potential mechanisms and the main components of SS in treating ALS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Xiaohui, Zhan, Yingshi, Yang, Biying, Du, Baoxin, Huang, Jingyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article: Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489316/ https://www.ncbi.nlm.nih.gov/pubmed/37682161 http://dx.doi.org/10.1097/MD.0000000000035101

Ejemplares similares

Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma
por: Mao, Jingxin, et al.
Publicado: (2023)

Mechanisms of P-Glycoprotein Modulation by Semen Strychni Combined with Radix Paeoniae Alba
por: Liu, Li-Li, et al.
Publicado: (2017)

Study on the Potential Mechanism of Semen Strychni against Myasthenia Gravis Based on Network Pharmacology and Molecular Docking with Experimental Verification
por: Fang, Pingfei, et al.
Publicado: (2022)

Renoprotective Effects of Total Glucosides from Paeony against Nephrotoxicity Induced by Total Alkaloids from Semen Strychni
por: Lv, Mingming, et al.
Publicado: (2017)

Isoliquiritigenin Alleviates Semen Strychni-Induced Neurotoxicity by Restoring the Metabolic Pathway of Neurotransmitters in Rats
por: Wang, Lu, et al.
Publicado: (2021)

Pharmacokinetics-Based Chronoefficacy of Semen Strychni and Tripterygium Glycoside Tablet Against Rheumatoid Arthritis
por: Lin, Jingpan, et al.
Publicado: (2021)

Exploring the synergistic pharmacological mechanism of Huoxiang Drink against irritable bowel syndrome by integrated data mining and network pharmacology
por: Wang, Ruo-Hui, et al.
Publicado: (2023)

Prophylactic Neuroprotection of Total Glucosides of Paeoniae Radix Alba against Semen Strychni-Induced Neurotoxicity in Rats: Suppressing Oxidative Stress and Reducing the Absorption of Toxic Components
por: Li, Shujuan, et al.
Publicado: (2018)

Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis
por: Taguchi, Y.-h., et al.
Publicado: (2018)

Eosinophil-Derived Neurotoxin Is Elevated in Patients with Amyotrophic Lateral Sclerosis
por: Liu, Guan-Ting, et al.
Publicado: (2013)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention
por: Cunha-Oliveira, Teresa, et al.
Publicado: (2020)

Investigation of the detoxification effect of licorice on Semen Strychni-induced acute toxicity in rats using a HPLC-Q-TOF/MS-based metabolomics approach
por: Xiang, Yalan, et al.
Publicado: (2020)

Exploring the Disease-Associated Microglia State in Amyotrophic Lateral Sclerosis
por: Jauregui, Carlota, et al.
Publicado: (2023)

Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis
por: Ingre, Caroline, et al.
Publicado: (2020)

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex
por: Nakayama, Yui, et al.
Publicado: (2013)

Autonomic laterality in caloric vestibular stimulation
por: Aghababaei Ziarati, Mohammadreza, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

An Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington's Disease
por: de Paula, Caroline Zocatelli, et al.
Publicado: (2015)

Edematous Hyponatremia Treated with Tolvaptan in a Patient with Amyotrophic Lateral Sclerosis
por: Kim, Gheun-Ho
Publicado: (2017)

Clinical Psychology and Amyotrophic Lateral Sclerosis
por: Pagnini, Francesco, et al.
Publicado: (2010)

Glial Cells in Amyotrophic Lateral Sclerosis
por: Lasiene, Jurate, et al.
Publicado: (2011)

The Cortical Signature of Amyotrophic Lateral Sclerosis
por: Agosta, Federica, et al.
Publicado: (2012)

Redox Regulation in Amyotrophic Lateral Sclerosis
por: Parakh, Sonam, et al.
Publicado: (2013)

Genetics of amyotrophic lateral sclerosis: an update
por: Chen, Sheng, et al.
Publicado: (2013)

Protein aggregation in amyotrophic lateral sclerosis
por: Blokhuis, Anna M., et al.
Publicado: (2013)

Risk factors for amyotrophic lateral sclerosis
por: Ingre, Caroline, et al.
Publicado: (2015)

Characteristics of pain in amyotrophic lateral sclerosis
por: Hanisch, Frank, et al.
Publicado: (2015)

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
por: Menke, Ricarda A. L., et al.
Publicado: (2016)

Pemphigus vulgaris and amyotrophic lateral sclerosis
por: Mokhtari, Fatemeh, et al.
Publicado: (2016)

Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
por: Szelechowski, M., et al.
Publicado: (2018)

Olfactory dysfunction in amyotrophic lateral sclerosis
por: Viguera, Cristina, et al.
Publicado: (2018)

RNA Dysregulation in Amyotrophic Lateral Sclerosis
por: Butti, Zoe, et al.
Publicado: (2019)

Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
por: Kirk, Siobhan E., et al.
Publicado: (2019)

Functional Biomarkers for Amyotrophic Lateral Sclerosis
por: Huynh, William, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6al569u18049qul3mgn46trj7r